Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

AH-9700, a promising centrally and peripherally acting treatment for incontinence

Aug. 13, 1998

Wound-healing efficacy of PGI2 analogue confirmed in preclinical models

Aug. 13, 1998

The peripheral vasodilator vintoperol has antioxidant action in vitro

Aug. 13, 1998

NSAID from Sigma-Tau is devoid of GI side effects

Aug. 13, 1998

Endothelin ETA antagonist YM-598 undergoes preclinical testing at Yamanouchi

Aug. 13, 1998

Antidepressant efficacy established with new addition to the Ampakine family

Aug. 13, 1998

NPY Y5 receptor antagonist suppresses feeding and reduces body weight in rodents

Aug. 13, 1998

Sumitomo proves cardioprotective activity of Na+/H+ exchange inhibitor SM-20550

Aug. 12, 1998

Profile of Solvay's dual NEP/ECE inhibitor in clinical testing

Aug. 12, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.